Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Blood Année : 2018

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Dates et versions

hal-02143630 , version 1 (29-05-2019)

Identifiants

Citer

Norbert Vey, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, et al.. Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients. Blood, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩. ⟨hal-02143630⟩

Collections

CNRS UNIV-AMU CRCM
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More